Search Results 1481-1490 of 17040 for monoclonal antibody

1. Neurology - Clinical trials - Mayo Clinic

   This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...

2. Pneumococcal 20-valent conjugate vaccine (intramuscular route) - Mayo Clinic

   It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...

3. DNA (cfDNA) Blood Test to Detect KRAS and Other Clinically Relevant Gene Mutations in Patients with Metastatic Colorectal Cancer

   ... antibody therapy) that are used in routine clinical practice. Currently, the only way to know if your tumor has one of these mutations is to take a tissue ...

4. MRD Guided, Fixed Duration Therapy With Loxo-305 and Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Patients with positive hepatitis B core antibody (anti-HBc) and negative HBsAg require hepatitis B polymerase chain reaction (PCR) evaluation. Patients who ...

5. A Study of GC012F, a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma(MM) - Mayo Clinic

   * Have received as part of their previous therapy a PI and IMiD and an antiCD38 antibody. * Have documented evidence of progressive disease by the IMWG ...

6. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   The purpose of this study is to evaluate the safety, clinical pharmacology and clinical activity of TNB-383B, a T-cell engaging bispecific antibody, in ...

7. Shortness of breath When to see a doctor - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI: Is gadolinium safe for people with kidney problems ...

8. A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies - Mayo Clinic

   - Prior treatment with an anti-TIGIT antibody. - Any active or prior autoimmune disease that required treatment within 3 years of the first dose of study ...

9. Pediatrics Clinical Trials - Medical Professionals

   Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

10. A Study to Evaluate Expanded Access to Mepolizumab for Patients with Hypereosinophilic Syndrome - Mayo Clinic

    Patients with history of serious allergic reaction (hypersensitivity/anaphylaxis) to anti-IL5 or other antibody therapy or known or suspected ...